H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.1% of adults in Chandler have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Census population 275,987. Arizona Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Chandler clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Chandler storefront.
Fibrin Matrix Therapy Products in Chandler, AZ for clinics & physicians. Fibrin matrix therapy supports wo… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 9.1% of adults in Chandler have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Census city-proper population is 275,987. If you are adding fibrin matrix therapy, start with that epidemiology and with Noridian Healthcare Solutions (JF) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Fibrin Matrix Therapy Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 9.1% of adults in Chandler have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Adult obesity in Chandler is 28.2% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 21% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JF / Noridian Healthcare Solutions, sibling states AK, ID, MT, ND, OR, SD, UT, WA, WY. Arizona Department of Health Services is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JF articles mapped. 9.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 9.1% of adults — 2.9 points below the U.S. 12% figure. Obesity is 28.2%; arthritis is 21%. That is place-level BRFSS modeling, not a clinic census and not a Chandler trial.
Arizona is in CMS MAC JF, administered by Noridian Healthcare Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Arizona.
Ask for the IFU, the lot-traceability packet, and the Noridian Healthcare Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Chandler fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Chandler, AZ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Chandler is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Chandler — 2.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Arizona Part B wound biologics follow this contractor (siblings: AK, ID, MT, ND, OR, SD, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Chandler. Useful for joint-program math; still needs a diagnosis and privileging.
No Chandler storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.